Aurore Bouyoukou Hounkpatin

Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

Kwaku Poku Asante, Salim Abdulla, Sélidji Todagbé Agnandji et al. · The Lancet Infectious Diseases · 2011 · 134 citations

A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children

Sodiomon B. Sirima, Benjamin Mordmüller, Paul Milligan et al. · Vaccine · 2016 · 98 citations

Vaccination, Vaccine Development, African Children +7

The Malaria Vaccine Candidate GMZ2 Elicits Functional Antibodies in Individuals From Malaria Endemic and Non-Endemic Areas

Micha Phill Grønholm Jepsen, Prajakta Jogdand, Susheel Kumar Singh et al. · The Journal of Infectious Diseases · 2013 · 69 citations

A Randomized Controlled Phase Ib Trial of the Malaria Vaccine Candidate GMZ2 in African Children

Sabine Bélard, Saadou Issifou, Aurore Bouyoukou Hounkpatin et al. · PLoS ONE · 2011 · 68 citations · Full text

Reduced antibody responses against Plasmodium falciparum vaccine candidate antigens in the presence of Trichuris trichiura

Meral Esen, Benjamin Mordmüller, Pablo M. De Salazar et al. · Vaccine · 2012 · 56 citations

Vaccination, Vaccine Development, Vaccine Target +8